1-20 of 20
Brian Link
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NOTCH pathway activation is mediated by DTX1 loss of function mutations in DLBCL

Free
Abigail Dropik, Melissa Hopper, Janek Walker, Joseph Novak, Miranda Siminski, Zilin Xianyu, Michelle Manske, Xiaosheng Wu, Mark Kaplan, Kerstin Wenzl, Vivekananda Sarangi, Matthew Maurer, Thomas Habermann, Brian Link, Baoyu Chen, Daniel Billadeau, Rebecca King, Thomas Witzig, Stephen Ansell, James Cerhan, Anne Novak
Journal: Blood
Blood (2025) 146 (Supplement 1): 1771.
https://doi.org/10.1182/blood-2025-1771
Published: 2025
Journal Articles

External validation of the early-stage classic Hodgkin lymphoma (cHL) international prognostication index (E-HIPI) in the german Hodgkin study group (GHSG) unfavorable clinical trials

Free
Angie Mae Rodday, Dennis Eichenauer, Janina Jablonski, Sven Borchmann, Hocine Tighiouart, Jenica Upshaw, David Hodgson, Matthew Maurer, Nicholas Counsell, Sara Rossetti, Zhu Cui, Ranjana Advani, Marc Andre, Massimo Federico, Annette Hay, Richard Hoppe, Martin Hutchings, Peter Johnson, Brian Link, Eric Mou, Kerry Savage, John Radford, James Cerhan, Peter Borchmann, Andrew Evens, Susan Parsons
Journal: Blood
Blood (2025) 146 (Supplement 1): 1845.
https://doi.org/10.1182/blood-2025-1845
Published: 2025
Journal Articles

Outcomes in the 2nd decade following follicular lymphoma (FL) diagnosis: Long-term follow-up from the university of Iowa/Mayo Clinic SPORE molecular epidemiology resource (MER)

Free
Jonathan Day, Melissa Larson, Eric Mou, Urshila Durani, Carla Casulo, Mazie Tsang, Umar Farooq, Patrizia Mondello, Jose Villasboas Bisneto, Carrie Thompson, Sergei Syrbu, Andrew Feldman, Christopher Flowers, Stephen Ansell, Thomas Witzig, Thomas Habermann, James Cerhan, Brian Link, Yucai Wang, Matthew Maurer
Journal: Blood
Blood (2025) 146 (Supplement 1): 1007.
https://doi.org/10.1182/blood-2025-1007
Published: 2025
Journal Articles

Survival differences in metropolitan versus nonmetropolitan/rural counties in the US: An analysis according to rural-urban continuum codes (RUCC) in the lymphoma epidemiology of outcomes (LEO) study cohort

Free
Mario Ballerini, Melissa Larson, James Foran, Matthew Bryant Howren, Michelle Hildebrandt, Pamela Allen, Shaun Riska, Matthew Maurer, Susan Slager, Andrew Feldman, David Jaye, Thomas Habermann, Jonathon Cohen, Brad Kahl, Peter Martin, Izidore S. Lossos, Jonathan Friedberg, Brian Link, Eric Mou, Chijioke Nze, Carrie Thompson, Annalynn Williams, Kathleen Yost, Christopher Flowers, James Cerhan
Journal: Blood
Blood (2025) 146 (Supplement 1): 6324.
https://doi.org/10.1182/blood-2025-6324
Published: 2025
Journal Articles

PET-adaptive beacopp- versus ABVD-based therapies for advanced-stage (AS) classic Hodgkin lymphoma (cHL): Survival comparisons leveraging a multi-state model and analyzing the impact of a-hipi scores across the disease course

Free
Zhu Cui, Angie Mae Rodday, Hocine Tighiouart, Nicholas Counsell, Sara Rossetti, Jenica Upshaw, Amy Kirkwood, Hongli Li, Ranjana Advani, Olivier Casasnovas, James Cerhan, Massimo Federico, Andrea Gallamini, Herve Ghesquieres, Eliza Hawkes, David Hodgson, Martin Hutchings, Peter Johnson, Brian Link, Eric Mou, John Radford, Kerry Savage, Deborah Stephens, Pier Luigi Zinzani, Matthew Maurer, Cedric Rossi, Andrew Evens, Susan Parsons
Journal: Blood
Blood (2025) 146 (Supplement 1): 129.
https://doi.org/10.1182/blood-2025-129
Published: 2025
Journal Articles

Performance of molecular classifiers relative to the international prognostic index (IPI) for overall and event-free survival in diffuse large B-cell lymphoma (DLBCL)

Free
George Cholack, Dominic Edelmann, Janek Walker, Joseph Novak, Yucai Wang, Eric Mou, Rebecca King, Sergei Syrbu, Jansen Seheult, Raphael Mwangi, Prokop Vodicka, Jonas Paludo, Grzegorz Nowakowski, Thomas Witzig, Eric Hsi, Stephen Ansell, Brian Link, Thomas Habermann, Matthew Maurer, Anne Novak, James Cerhan
Journal: Blood
Blood (2025) 146 (Supplement 1): 5301.
https://doi.org/10.1182/blood-2025-5301
Published: 2025
Journal Articles

FLP-R: A clinical prediction model for follicular lymphoma Prognosis in the Relapsed/refractory setting

Free
Matthew Maurer, Melissa Larson, Urshila Durani, Mazie Tsang, Eric Mou, Jonathon Cohen, Jonathan Day, Jennifer Bøgh Jørgensen, Christopher Strouse, Jose Villasboas Bisneto, Andrew Feldman, Sergei Syrbu, Richard Burack, Dai Chihara, Elliot Cahn, David Russler-Germain, Stephen Ansell, Yucai Wang, Loretta Nastoupil, Peter Martin, Izidore S. Lossos, Jean Koff, Thomas Habermann, Tarec Christoffer El-Galaly, James Cerhan, Christopher Flowers, Brian Link, Carla Casulo
Journal: Blood
Blood (2025) 146 (Supplement 1): 5354.
https://doi.org/10.1182/blood-2025-5354
Published: 2025
Journal Articles

Bioflipi scores define distinct immune profiles in follicular lymphoma

Free
Jordan Krull, Qin Ma, Emmanuel Contreras Guzman, Rebecca King, Andrew Feldman, Surendra Dasari, Diwakar Suresh, Jose Villasboas Bisneto, Matthew Maurer, Brian Link, Eric Hsi, Grzegorz Nowakowski, Thomas Habermann, Anne Novak, Melissa Larson, James Cerhan, Stephen Ansell, Patrizia Mondello
Journal: Blood
Blood (2025) 146 (Supplement 1): 5328.
https://doi.org/10.1182/blood-2025-5328
Published: 2025
Journal Articles

Elevation of Serum Free Light Chains Are Common In Lymphoma and Associated with Poor Event Free and Overall Survival

Free
Matthew J Maurer, James Cerhan, MD, PhD, Jerry A Katzmann, PhD, Brian Link, Ivana N Micallef, MD, Joseph Colgan, MD, Thomas M. Habermann, MD, David James Inwards, MD, Svetomir Markovic, MD, PhD, Stephen M. Ansell, MD, PhD, Luis Porrata, MD, Patrick B Johnston, MD, Grzegorz S. Nowakowski, MD, Carrie A Thompson, MD, Mamta Gupta, Ph.D, Sergei I Syrbu, MD, Paul Kurtin, MD, William Macon, MD, Thomas E. Witzig, MD
Journal: Blood
Blood (2010) 116 (21): 4136.
https://doi.org/10.1182/blood.V116.21.4136.4136
Published: 2010
Journal Articles

Pretreatment Serum Cytokines Predict Early Disease Relapse and a Poor Prognosis In Diffuse Large B-Cell Lymphoma (DLBCL) Patients

Free
Stephen M. Ansell, MD, PhD, Matthew J Maurer, Steven C Ziesmer, Susan L Slager, PhD, Thomas M Habermann, MD, Brian Link, Thomas E Witzig, MD, James Cerhan, MD, PhD, Anne J. Novak, PhD
Journal: Blood
Blood (2010) 116 (21): 991.
https://doi.org/10.1182/blood.V116.21.991.991
Published: 2010
Journal Articles

Genetic Polymorphisms In Genes Involved In R-CHOP Metabolism and Event-Free and Overall Survival In Diffuse Large B-Cell Lymphoma

Free
James R Cerhan, MD, PhD, Thomas M Habermann, MD, Matthew J Maurer, MS, James E Wooldridge, MD, Stephen M Ansell, MD, PhD, Grzegorz S. Nowakowski, MD, Ivana N Micallef, MD, Carrie A Thompson, MD, Alice H Wang, BA, William R Macon, MD, Sergei I Syrbu, MD, Susan L Slager, PhD, Thomas E Witzig, MD, Brian Link
Journal: Blood
Blood (2010) 116 (21): 996.
https://doi.org/10.1182/blood.V116.21.996.996
Published: 2010
Journal Articles

Germline Variation in TNF and NF-Kappa B Pathways and Prognosis In Mantle Cell Lymphoma

Free
Thomas M. Habermann, MD, Matthew J Maurer, Brian Link, William R Macon, Alice H. Wang, David J Inwards, MD, Thomas E. Witzig, MD, Susan L Slager, PhD, James R Cerhan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4127.
https://doi.org/10.1182/blood.V116.21.4127.4127
Published: 2010
Journal Articles

Does An Anthracycline Make a Difference for Follicular Lymphoma (FL) Grade 3? Patterns of Care and Treatment Outcomes of Grade 3 FL From the National LymphoCare Study (NLCS)

Free
Christopher R Flowers, MD, MS, Michael Taylor, PharmD, PhD, Michelle Byrtek, PhD, Jamie H. Hirata, PharmD, James Cerhan, MD, PhD, John Hainsworth, MD, Brian Link, Thomas P. Miller, MD, Hildy Dillon, MPH, Jonathan W. Friedberg, MD
Journal: Blood
Blood (2010) 116 (21): 1768.
https://doi.org/10.1182/blood.V116.21.1768.1768
Published: 2010
Journal Articles

Pralatrexate Is Effective In Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL) with Prior Ifosfamide, Carboplatin, and Etoposide (ICE)-Based Regimens

Free
Andre Goy, MD, Barbara Pro, MD, Kerry Joanne Savage, MD, BSc, MSc, Nancy L. Bartlett, MD, Mary Jo Lechowicz, MD, Eric D Jacobsen, MD, Faith Young, Michael Crump, MD, FRCPC, Hossein Borghaei, DO, Brian Link, Steven M. Fruchtman, MD, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1753.
https://doi.org/10.1182/blood.V116.21.1753.1753
Published: 2010
Journal Articles

A Phase II Study of the Farnesyltransferase Inhibitor Tipifarnib Demonstrates Anti-Tumor Activity In Patients with Relapsed and Refractory Lymphomas

Free
Thomas E. Witzig, MD, Tang Hui, PhD, Ivana N Micallef, MD, Stephen M. Ansell, MD, PhD, Brian Link, David James Inwards, MD, Luis Porrata, MD, Patrick B Johnston, MD, PhD, Joseph Colgan, Svetomir Markovic, MD, PhD, Grzegorz S. Nowakowski, MD, Carrie A Thompson, MD, Cristine Allmer, Matthew J Maurer, George Weiner, MD, Raymond J. Hohl, MD, PhD, Paul Kurtin, MD, Husheng Ding, PhD, Loegering A David, MD, Paula A Schneider, Kevin L Peterson, Thomas M. Habermann, MD, Scott H. Kaufmann, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 287.
https://doi.org/10.1182/blood.V116.21.287.287
Published: 2010
Journal Articles

Vitamin D Insufficiency and Prognosis In Chronic Lymphocytic Leukemia (CLL)

Free
Tait Shanafelt, MD, Matthew Drake, Matthew Mauer, Cristine Allmer, Kari Rabe, Susan Slager, PhD, George Weiner, MD, Timothy Call, MD, Brian Link, Clive S. Zent, MD, Neil E. Kay, Curtis Hanson, Thomas E. Witzig, MD, James Cerhan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2408.
https://doi.org/10.1182/blood.V116.21.2408.2408
Published: 2010
Journal Articles

Monoclonal and Polyclonal Serum Free Light Chains and Clinical Outcome In Chronic Lymphocytic Leukemia

Free
Matthew J Maurer, James Cerhan, MD, PhD, Jerry A Katzmann, PhD, Brian Link, Cristine Allmer, Clive S. Zent, MD, Timothy Call, MD, Kari Rabe, Curtis A. Hanson, MD, Neil E. Kay, Susan Slager, PhD, Thomas E. Witzig, MD, Tait Shanafelt, MD
Journal: Blood
Blood (2010) 116 (21): 2409.
https://doi.org/10.1182/blood.V116.21.2409.2409
Published: 2010
Journal Articles

Investigation of CLL-Susceptibility Loci with Monoclonal B-Cell Lymphocytosis (MBL) Risk and Confirmation of Recently Reported CLL-Susceptibility Loci

Free
Susan Slager, PhD, Kari Rabe, Sara Achenbach, Celine Vachon, PhD, Lynn Goldin, PhD, Sara Strom, PhD, Mark C Lanasa, MD, PhD, Logan G. Spector, PhD, Laura Z Rassenti, PhD, Jose Leis, Nicola Camp, Martha Glenn, MD, Neil E. Kay, Julie M Cunningham, PhD, Curtis A. Hanson, MD, Gerald E Marti, MD, PhD, J. Brice Weinberg, MD, Vicki A. Morrison, MD, Brian Link, Timothy Call, MD, Neil Caporaso, MD, James Cerhan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2443.
https://doi.org/10.1182/blood.V116.21.2443.2443
Published: 2010
Journal Articles

Imaging of Peripheral Blood Mononuclear Cells (PBMC) Trafficking in Patients with Non-Hodgkin’s Lymphoma (NHL) Prior to and Following Therapy.

Free
George Weiner, MD, Gregory Wiseman, MD, Thomas Witzig, MD, Brian Link, MD, James Wooldridge, MD, James Ponto, MD, Malik Juweid, MD
Journal: Blood
Blood (2005) 106 (11): 2823.
https://doi.org/10.1182/blood.V106.11.2823.2823
Published: 2005
Journal Articles

TLR9 Agonist Immunomodulator Treatment of Cutaneous T-Cell Lymphoma (CTCL) with CPG7909.

Free
Youn Kim, MD, Michael Girardi, MD, Madeline Duvic, MD, Timothy Kuzel, MD, Alain Rook, MD, Brian Link, MD, Lauren Pinter-Brown, MD, Carol Comerci, Sonja McAuley, Tess Schmalbach, MD
Journal: Blood
Blood (2004) 104 (11): 743.
https://doi.org/10.1182/blood.V104.11.743.743
Published: 2004